FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds represented by the formula (I)
, or pharmaceutically acceptable salts thereof.
EFFECT: technical result: novel compounds of formula (I) having an antagonistic action against group II metabotropic glutamate receptor, which can be used as a therapeutic agent in disorders such as Alzheimer's disease.
19 cl, 10 tbl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BICYCLIC LACTAMS AND METHODS OF USE THEREOF | 2016 |
|
RU2827714C1 |
| BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
| BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| MONOCYCLIC PYRIDINE DERIVATIVE | 2014 |
|
RU2645352C2 |
| CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
| PRODRUG FORMING COMPOUNDS | 2014 |
|
RU2667942C2 |
| INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
| CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
Authors
Dates
2018-06-29—Published
2014-02-26—Filed